Cargando…

Outcome and toxicity of hypofractionated image-guided SABR for spinal oligometastases

BACKGROUND: To investigate progression free survival (PFS), local control (LC) and overall survival (OS) outcomes for patients treated with spine hypofractionated stereotactic ablative radiotherapy (SABR) and to evaluate possible predictors of rapid progression in view of a correct patient selection...

Descripción completa

Detalles Bibliográficos
Autores principales:	Billiet, Charlotte, Joye, Ines, Mercier, Carole, Depuydt, Lieselotte, De Kerf, Geert, Vermeulen, Peter, Van Laere, Steven, Van de Kelft, Erik, Meijnders, Paul, Verellen, Dirk, Dirix, Piet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334439/ https://www.ncbi.nlm.nih.gov/pubmed/32642561 http://dx.doi.org/10.1016/j.ctro.2020.06.011

Ejemplares similares

Precision of image-guided spinal stereotactic ablative radiotherapy and impact of positioning variables
por: Billiet, Charlotte, et al.
Publicado: (2022)

A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)
por: Mercier, Carole, et al.
Publicado: (2019)

A phase I dose-escalation trial of stereotactic ablative body radiotherapy for non-spine bone and lymph node metastases (DESTROY-trial)
por: Mercier, Carole, et al.
Publicado: (2018)

A geometry and dose-volume based performance monitoring of artificial intelligence models in radiotherapy treatment planning for prostate cancer
por: De Kerf, Geert, et al.
Publicado: (2023)

The use of simulation-CT’s as a coronavirus disease 2019 screening tool during the severe acute respiratory syndrome coronavirus 2 pandemic()
por: Nevens, Daan, et al.
Publicado: (2020)

Survival Outcomes and Pattern of Relapse After SABR for Oligometastatic Prostate Cancer
por: Mercier, Carole, et al.
Publicado: (2022)

Automated enumeration and phenotypic characterization of CTCs and tdEVs in patients with metastatic castration resistant prostate cancer
por: Oeyen, Steffi, et al.
Publicado: (2020)

Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5
por: Olson, Robert, et al.
Publicado: (2018)

Evaluation of the optimal combinations of modulation factor and pitch for Helical TomoTherapy plans made with TomoEdge using Pareto optimal fronts
por: De Kerf, Geert, et al.
Publicado: (2015)

Machine learning-based treatment couch parameter prediction in support of surface guided radiation therapy
por: De Kerf, Geert, et al.
Publicado: (2022)

Accelerated Adaptation of Ultrahypofractionated Radiation Therapy for Breast Cancer at the Time of the COVID-19 Pandemic
por: Machiels, M., et al.
Publicado: (2021)

Comparing treatment uncertainty for ultra- vs. standard-hypofractionated breast radiation therapy based on in-vivo dosimetry
por: Fiagan, Yawo A.C., et al.
Publicado: (2022)

Fast Helical Tomotherapy in a head and neck cancer planning study: is time priceless?
por: Van Gestel, Dirk, et al.
Publicado: (2015)

Epidemiology of spinal metastases, metastatic epidural spinal cord compression and pathologic vertebral compression fractures in patients with solid tumors: A systematic review
por: Van den Brande, Ruben, et al.
Publicado: (2022)

Oligometastases in prostate cancer: Metabolic response in follow-up PSMA-PET-CTs after hypofractionated IGRT
por: Baumann, René, et al.
Publicado: (2017)

Hypofractionated Stereotactic Radiotherapy for Non-breast or Prostate Cancer Oligometastases: A Tail of Survival Beyond 10 Years
por: Aujla, Khush S., et al.
Publicado: (2019)

The Road to Dissemination: The Concept of Oligometastases and the Barriers for Widespread Disease
por: AlGhamdi, Hamza, et al.
Publicado: (2022)

Clinical outcome of hypofractionated breath-hold image-guided SABR of primary lung tumors and lung metastases
por: Boda-Heggemann, Judit, et al.
Publicado: (2014)

Clinical evaluation of an endorectal immobilization system for use in prostate hypofractionated Stereotactic Ablative Body Radiotherapy (SABR)
por: Nicolae, Alexandru, et al.
Publicado: (2015)

Molecular profiles to biology and pathways: a systems biology approach
por: Van Laere, Steven, et al.
Publicado: (2016)

Hypofractionated image-guided breath-hold SABR (Stereotactic Ablative Body Radiotherapy) of liver metastases – clinical results
por: Boda-Heggemann, Judit, et al.
Publicado: (2012)

Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases†
por: Yamashita, Hideomi, et al.
Publicado: (2016)

The EADGENE and SABRE post-analyses workshop
por: Jaffrezic, Florence, et al.
Publicado: (2009)

Inflammatory breast carcinoma as a model of accelerated self-metastatic expansion by intravascular growth
por: Vermeulen, P B, et al.
Publicado: (2009)

Stereotactic radiotherapy for lung oligometastases
por: Falcinelli, Lorenzo, et al.
Publicado: (2022)

Stereotactic radiotherapy for liver oligometastases
por: Menichelli, Claudia, et al.
Publicado: (2022)

Stereotactic radiotherapy for adrenal oligometastases
por: Borghesi, Simona, et al.
Publicado: (2022)

Stereotactic radiotherapy for bone oligometastases
por: Colosimo, Caterina, et al.
Publicado: (2022)

Stereotactic radiotherapy for brain oligometastases
por: Lupattelli, Marco, et al.
Publicado: (2022)

Model Calibration of Pharmacokinetic-Pharmacodynamic Lung Tumour Dynamics for Anticancer Therapies
por: Ghita, Maria, et al.
Publicado: (2022)

Quantification of hyperpolarisation efficiency in SABRE and SABRE-Relay enhanced NMR spectroscopy
por: Richardson, Peter M., et al.
Publicado: (2018)

In vivo dosimetry for patients with prostate cancer to assess possible impact of bladder and rectum preparation
por: Fiagan, Yawo A.C., et al.
Publicado: (2020)

Oligometastases/Oligo-Recurrence of Lung Cancer
por: Niibe, Yuzuru, et al.
Publicado: (2013)

Oligometastases in prostate cancer: Ablative treatment
por: Palacios-Eito, Amalia, et al.
Publicado: (2019)

Stereotactic radiotherapy for oligometastases in the lymph nodes
por: Pasqualetti, Francesco, et al.
Publicado: (2022)

Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial
por: Lieverse, Relinde I. Y., et al.
Publicado: (2020)

Perspective on what Seems Simple to Manage: Odontoid Fractures
por: Van de Kelft, Erik
Publicado: (2019)

SABRE : sistema de reservaciones para agencias de viajes
por: Mata Hernández, Elizabeth
Publicado: (1999)

SABRE: a system for the assessment of body radioactivity ; 2, main features of SABRE 3
por: Venn, J B
Publicado: (1978)

The Yin and Yang of Cytoreductive SBRT in Oligometastases and Beyond
por: Onderdonk, Benjamin E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_56jqopbopbcjq54gi1h5n0qfs9